Expression of prostate-specific membrane antigen (PSMA), increases cell folate uptake and proliferation and suggests a novel role for PSMA in the uptake of the non-polyglutamated folate, folic acid.
about
Prostate-specific membrane antigen as a target for cancer imaging and therapyImpact of folate intake on prostate cancer recurrence following definitive therapy: data from CaPSURE™.Size-Dependent Photodynamic Anticancer Activity of Biocompatible Multifunctional Magnetic Submicron Particles in Prostate Cancer Cells.GCPII imaging and cancer.Study on the prostate cancer-targeting mechanism of aptamer-modified nanoparticles and their potential anticancer effect in vivo.T cells bearing a chimeric antigen receptor against prostate-specific membrane antigen mediate vascular disruption and result in tumor regression.Increased cancer cell proliferation in prostate cancer patients with high levels of serum folateRational truncation of an RNA aptamer to prostate-specific membrane antigen using computational structural modeling.Targeted inhibition of prostate cancer metastases with an RNA aptamer to prostate-specific membrane antigen.Folate-targeted pH-responsive calcium zoledronate nanoscale metal-organic frameworks: Turning a bone antiresorptive agent into an anticancer therapeutic.A novel gene delivery composite system based on biodegradable folate-poly (ester amine) polymer and thermosensitive hydrogel for sustained gene release.Design and Application of Magnetic-based Theranostic Nanoparticle SystemsOpposing roles of folate in prostate cancer.Prostate-Specific Membrane Antigen Targeted Polymersomes for Delivering Mocetinostat and Docetaxel to Prostate Cancer Cell Spheroids.Glutamate carboxypeptidase II in diagnosis and treatment of neurologic disorders and prostate cancerPET imaging in prostate cancer: focus on prostate-specific membrane antigenThe prostate-specific membrane antigen: lessons and current clinical implications from 20 years of research.The therapeutic and diagnostic potential of the prostate specific membrane antigen/glutamate carboxypeptidase II (PSMA/GCPII) in cancer and neurological diseasePSMA-Targeted Theranostic Nanocarrier for Prostate Cancer.Evaluation of prostate-specific membrane antigen as an imaging reporter.Co-expression and impact of prostate specific membrane antigen and prostate specific antigen in prostatic pathologiesComparison of Prostate-Specific Membrane Antigen-Based 18F-DCFBC PET/CT to Conventional Imaging Modalities for Detection of Hormone-Naïve and Castration-Resistant Metastatic Prostate Cancer.PSMA-Based [(18)F]DCFPyL PET/CT Is Superior to Conventional Imaging for Lesion Detection in Patients with Metastatic Prostate Cancer.¹⁸F-DCFBC PET/CT for PSMA-Based Detection and Characterization of Primary Prostate Cancer.Characterization of prostate cancer cell progression in zebrafish xenograft model.Current Advances in Aptamers for Cancer Diagnosis and Therapy.68Ga-PSMA-11 PET/CT in primary staging of prostate carcinoma: preliminary results on differences between black and white South-Africans.Review of Gallium-68 PSMA PET/CT Imaging in the Management of Prostate Cancer.Extreme Prostate-Specific Antigen Response to Infusional 5-Flourouracil in Castrate-Resistant Prostate Cancer.Comparison of 68Ga-labelled PSMA-11 and 11C-choline in the detection of prostate cancer metastases by PET/CT
P2860
Q26799439-182AA679-3775-42CF-A3FB-4F650170BC98Q30671456-1CD87D79-EF92-4CC2-B100-8E9A1BB586B5Q31127810-F465C2ED-0E6E-4A07-B4BC-D3640153683AQ33827632-18419F03-F88C-4EA2-AF3D-57D8D1D377D6Q34584347-D6EBF772-55FD-452E-BEA8-EFCA5ACDA1AAQ34893030-7CAB63AD-3327-409D-A447-0083881961ECQ35061858-20E7D507-6C32-48BF-AC72-AF178E2F88F6Q35413768-A2A67A54-4A6E-45E9-827B-884CB2C65F0DQ35600421-867DBF0F-E531-4228-8543-E5A4762CD64FQ36505631-0ABBCE5E-92A5-428D-A4E3-510C801E251CQ36588544-841EC5DF-5CC0-4DBC-98E9-42524F428901Q36940177-B2459CFE-6982-4E75-A001-4F9807DF27D5Q37366024-06EC9CC1-BBFE-4391-92AD-9D710C8F823BQ37460152-02186634-D0BB-4DBC-910A-EDE683A1BAF5Q37972920-FC7301E1-27E2-4FFE-9EFB-BA015175D21FQ38099369-D5057DBC-2D3E-4674-90CF-0C0471EF05BFQ38169828-9ABF89AB-FD9A-4E29-9D85-FF8ABE4ACE93Q38831232-3F8F1BAE-E466-4CBD-8626-03E37B9C1AA6Q41114317-0472B9B7-861F-4BC9-914A-A6BF1AC7278CQ41462083-4C94AA46-D674-4570-B0DB-296A465B0CA9Q41839859-1D55C02C-9837-46A5-BBB3-2654D491EEB5Q42060482-3A19E22B-311C-4E12-B3DE-07A022FCF083Q42328242-99F54D98-4B40-44AF-A04A-05FED32C2199Q43156292-C054EFC8-2CED-4389-84BC-9F74C04B350EQ47426582-8647EDF7-F535-4F55-80F7-F6E8A7436C8DQ47561686-F16BD1C7-F701-4DA6-81F2-9E0BEAF86AA0Q47660762-F9703EB8-516A-4895-A8B2-E512D8520F49Q50034009-EA9C7B82-6CF7-405B-BD4A-E25EC4543B0EQ52743840-797747F7-8544-493A-AC7D-F1562C559512Q57661498-54F6553E-02BF-4918-94BB-9AE49A62096A
P2860
Expression of prostate-specific membrane antigen (PSMA), increases cell folate uptake and proliferation and suggests a novel role for PSMA in the uptake of the non-polyglutamated folate, folic acid.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Expression of prostate-specifi ...... glutamated folate, folic acid.
@ast
Expression of prostate-specifi ...... glutamated folate, folic acid.
@en
type
label
Expression of prostate-specifi ...... glutamated folate, folic acid.
@ast
Expression of prostate-specifi ...... glutamated folate, folic acid.
@en
prefLabel
Expression of prostate-specifi ...... glutamated folate, folic acid.
@ast
Expression of prostate-specifi ...... glutamated folate, folic acid.
@en
P2093
P356
P1433
P1476
Expression of prostate-specifi ...... glutamated folate, folic acid.
@en
P2093
Clifford E Berkman
Dean J Bacich
Denise S O'Keefe
Joseph K Choi
Veronica Yao
P2860
P304
P356
10.1002/PROS.21065
P577
2010-02-01T00:00:00Z